Lenograstim
Lenograstim
Lenograstim (pronounced: leh-noh-GRAS-tim) is a granulocyte colony-stimulating factor (G-CSF) used in the treatment of neutropenia, a condition characterized by low levels of neutrophils in the blood.
Etymology
The term "Lenograstim" is derived from the Greek words "lenos" meaning "wine press" and "grastis" meaning "stimulator". This is in reference to the drug's ability to stimulate the production of neutrophils, similar to how a wine press stimulates the extraction of juice from grapes.
Usage
Lenograstim is used to stimulate the production of neutrophils in the bone marrow of patients undergoing chemotherapy or bone marrow transplantation. This helps to prevent infections that can occur due to low neutrophil counts. It is also used in the mobilization of hematopoietic stem cells for transplantation.
Related Terms
- Granulocyte colony-stimulating factor: A type of growth factor that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.
- Neutropenia: A condition characterized by an abnormally low number of neutrophils, a type of white blood cell that helps fight off infections.
- Chemotherapy: A type of cancer treatment that uses drugs to kill cancer cells.
- Bone marrow transplantation: A procedure that replaces damaged or destroyed bone marrow with healthy bone marrow stem cells.
- Hematopoietic stem cells: Cells in the bone marrow that give rise to all the different types of blood cells.
External links
- Medical encyclopedia article on Lenograstim
- Wikipedia's article - Lenograstim
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski